Back to Search
Start Over
The Economics of Malaria Vaccine Development.
- Source :
-
Trends in Parasitology . Mar2017, Vol. 33 Issue 3, p154-156. 3p. - Publication Year :
- 2017
-
Abstract
- Vaccines that do not take a comprehensive endpoint view of the pathogen population they want to tackle early in their developmental process, may find it financially prohibitive to redesign them once they have progressed down a costly regulatory and human trial pathway. Specifically, the lead malaria vaccine candidate RTS,S has limited ability to tackle parasite polymorphism and may induce sex-specific nonspecific effects (NSEs). [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14714922
- Volume :
- 33
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Trends in Parasitology
- Publication Type :
- Academic Journal
- Accession number :
- 121360017
- Full Text :
- https://doi.org/10.1016/j.pt.2017.01.006